These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 30998372

  • 1. Multifunctionalized Micelles Facilitate Intracellular Doxorubicin Delivery for Reversing Multidrug Resistance of Breast Cancer.
    Cao A, Ma P, Yang T, Lan Y, Yu S, Liu L, Sun Y, Liu Y.
    Mol Pharm; 2019 Jun 03; 16(6):2502-2510. PubMed ID: 30998372
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y, Zhou C, Wei S, Yang T, Lan Y, Cao A, Yang J, Hou Y.
    Colloids Surf B Biointerfaces; 2018 Oct 01; 170():330-340. PubMed ID: 29936386
    [Abstract] [Full Text] [Related]

  • 3. CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery.
    Liu Y, Zhou C, Wang W, Yang J, Wang H, Hong W, Huang Y.
    Mol Pharm; 2016 Dec 05; 13(12):4209-4221. PubMed ID: 27796093
    [Abstract] [Full Text] [Related]

  • 4. Reversing multidrug resistance by intracellular delivery of Pluronic® P85 unimers.
    Hong W, Chen D, Zhang X, Zeng J, Hu H, Zhao X, Qiao M.
    Biomaterials; 2013 Dec 05; 34(37):9602-14. PubMed ID: 24021757
    [Abstract] [Full Text] [Related]

  • 5. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
    Qiu L, Qiao M, Chen Q, Tian C, Long M, Wang M, Li Z, Hu W, Li G, Cheng L, Cheng L, Hu H, Zhao X, Chen D.
    Biomaterials; 2014 Dec 05; 35(37):9877-9887. PubMed ID: 25201738
    [Abstract] [Full Text] [Related]

  • 6. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
    Nguyen DH, Lee JS, Bae JW, Choi JH, Lee Y, Son JY, Park KD.
    Int J Pharm; 2015 Nov 10; 495(1):329-335. PubMed ID: 26325307
    [Abstract] [Full Text] [Related]

  • 7. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T, Chen D, Liu K, Qi Y, Tian Y, Sun P, Liu Y, Li Z.
    ACS Appl Mater Interfaces; 2015 Aug 19; 7(32):18064-75. PubMed ID: 26214761
    [Abstract] [Full Text] [Related]

  • 8. Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer.
    Lv L, Qiu K, Yu X, Chen C, Qin F, Shi Y, Ou J, Zhang T, Zhu H, Wu J, Liu C, Li G.
    J Biomed Nanotechnol; 2016 May 19; 12(5):973-85. PubMed ID: 27305819
    [Abstract] [Full Text] [Related]

  • 9. Transferrin receptor-targeted pH-sensitive micellar system for diminution of drug resistance and targetable delivery in multidrug-resistant breast cancer.
    Gao W, Ye G, Duan X, Yang X, Yang VC.
    Int J Nanomedicine; 2017 May 19; 12():1047-1064. PubMed ID: 28223798
    [Abstract] [Full Text] [Related]

  • 10. Mixed Micelles for Targeted and Efficient Doxorubicin Delivery to Multidrug-Resistant Breast Cancer Cells.
    Jung H, Mok H.
    Macromol Biosci; 2016 May 19; 16(5):748-58. PubMed ID: 26806493
    [Abstract] [Full Text] [Related]

  • 11. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y, Zhang Y, Zhang W, Sun C, Wu J, Tang J.
    Colloids Surf B Biointerfaces; 2016 Feb 01; 138():60-9. PubMed ID: 26655793
    [Abstract] [Full Text] [Related]

  • 12. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
    Yang H, Deng L, Li T, Shen X, Yan J, Zuo L, Wu C, Liu Y.
    J Biomed Nanotechnol; 2015 Dec 01; 11(12):2124-36. PubMed ID: 26510307
    [Abstract] [Full Text] [Related]

  • 13. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
    Chen Y, Zhang W, Huang Y, Gao F, Sha X, Fang X.
    Int J Pharm; 2015 Jul 05; 488(1-2):44-58. PubMed ID: 25899286
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity.
    Wei Z, Yuan S, Hao J, Fang X.
    Eur J Pharm Biopharm; 2013 Feb 05; 83(2):266-74. PubMed ID: 23089310
    [Abstract] [Full Text] [Related]

  • 15. Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer.
    Mao J, Qiu L, Ge L, Zhou J, Ji Q, Yang Y, Long M, Wang D, Teng L, Chen J.
    Biomed Pharmacother; 2021 Feb 05; 134():111108. PubMed ID: 33341670
    [Abstract] [Full Text] [Related]

  • 16. Rational Design of Multifunctional Polymeric Nanoparticles Based on Poly(l-histidine) and d-α-Vitamin E Succinate for Reversing Tumor Multidrug Resistance.
    Li Z, Chen Q, Qi Y, Liu Z, Hao T, Sun X, Qiao M, Ma X, Xu T, Zhao X, Yang C, Chen D.
    Biomacromolecules; 2018 Jul 09; 19(7):2595-2609. PubMed ID: 29618203
    [Abstract] [Full Text] [Related]

  • 17. Rational design of multifunctional micelles against doxorubicin-sensitive and doxorubicin-resistant MCF-7 human breast cancer cells.
    Hong W, Shi H, Qiao M, Gao X, Yang J, Tian C, Zhang D, Niu S, Liu M.
    Int J Nanomedicine; 2017 Jul 09; 12():989-1007. PubMed ID: 28243082
    [Abstract] [Full Text] [Related]

  • 18. Pluronic micelles with suppressing doxorubicin efflux and detoxification for efficiently reversing breast cancer resistance.
    Cheng X, Lv X, Xu J, Zheng Y, Wang X, Tang R.
    Eur J Pharm Sci; 2020 Apr 15; 146():105275. PubMed ID: 32087259
    [Abstract] [Full Text] [Related]

  • 19. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
    Yu P, Yu H, Guo C, Cui Z, Chen X, Yin Q, Zhang P, Yang X, Cui H, Li Y.
    Acta Biomater; 2015 Mar 15; 14():115-24. PubMed ID: 25498306
    [Abstract] [Full Text] [Related]

  • 20. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
    Liu HN, Guo NN, Guo WW, Huang-Fu MY, Vakili MR, Chen JJ, Xu WH, Wei QC, Han M, Lavasanifar A, Gao JQ.
    Acta Pharmacol Sin; 2018 Oct 15; 39(10):1681-1692. PubMed ID: 29849132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.